Abstract-Inflammation is a key event in the development of atherosclerosis. Nuclear factor-B (NF-B) is important in the inflammatory response regulation. The effector peptide of the renin angiotensin system Angiotensin II (Ang II) activates NF-B and upregulates some related proinflammatory genes. Our aim was to investigate whether other angiotensin-related peptides, as the N-terminal degradation peptide Ang IV, could regulate proinflammatory factors (activation of NF-B and related genes) in cultured vascular smooth muscle cells (VSMCs). In these cells, Ang IV increased NF-B DNA binding activity, caused nuclear translocation of p50/p65 subunits, cytosolic IB degradation and induced NF-B-dependent gene transcription. Ang II activates NF-B via AT 1 and AT 2 receptors, but AT 1 or AT 2 antagonists did not inhibit NF-B activation caused by Ang IV. In VSMC from AT 1a receptor knockout mice, Ang IV also activated NF-B pathway. In those cells, the AT 4 antagonist divalinal diminished dose-dependently Ang IV-induced NF-B activation and prevented IB degradation, but had no effect on the Ang II response, indicating that Ang IV activates the NF-B pathway via AT 4 receptors. Ang IV also increased the expression of proinflammatory factors under NF-B control, such as MCP-1, IL-6, TNF-␣, ICAM-1, and PAI-1, which were blocked by the AT 4 antagonist. Our results reveal that Ang IV, via AT 4 receptors, activates NF-B pathway and increases proinflammatory genes. These data indicate that Ang IV possesses proinflammatory properties, suggesting that this Ang degradation peptide could participate in the pathogenesis of cardiovascular diseases.